Hikal Limited Overview
Pro stress-test →Hikal Ltd. is a leading Indian company providing pharmaceutical and crop protection solutions, including Active Pharmaceutical Ingredients (APIs), intermediates, and specialty chemicals. The company is the preferred partner for pharmaceuticals and crop protection companies, with a vision to be the leading global fine chemical provider to the Pharmaceutical, Crop Protection, and Specialty Chemical industries.
Strategic Profile
Pro stress-test →Hikal is engaged in the business of pharmaceuticals, crop protection, and specialty chemicals. Strategic shifts towards enhancing its CDMO services and diversifying into personal care and specialty chemicals are expected to drive future growth. However, the company is currently facing headwinds with recent regulatory challenges and declining profitability.
Competitive Landscape
Pro stress-test →In the last 1 year, Torrent Pharmaceuticals Ltd has given 23.1% return, outperforming Hikal stock by 64.8%. Hikal competes against larger integrated pharma and specialty chemicals companies in India and globally. The company's growth underperformance reflects competitive pressures and regulatory challenges in the pharmaceutical manufacturing space.
Industry Context
Hikal Limited operates in Pharmaceuticals & Biotechnology - Fine Chemicals / Active Pharmaceutical Ingredients.
Key facts
Founded: 1988 · Headquarters: Mumbai, India · Revenue: ₹316.2 Cr (Q2 FY26) · Market cap: ₹2,845.5 Cr (Nov 2025)